US 12,220,559 B2
System for administering a medicament
Michael Robert Mensinger, San Diego, CA (US); and Sean Saint, San Diego, CA (US)
Assigned to Medtronic MiniMed, Inc., Northridge, CA (US)
Filed by Medtronic MiniMed, Inc., Northridge, CA (US)
Filed on Apr. 10, 2023, as Appl. No. 18/132,510.
Application 18/132,510 is a continuation of application No. 16/784,061, filed on Feb. 6, 2020, granted, now 11,628,255, issued on Apr. 18, 2023.
Application 16/784,061 is a continuation of application No. 15/025,026, granted, now 10,754,927, issued on Aug. 25, 2020, previously published as PCT/US2014/056336, filed on Sep. 18, 2014.
Claims priority of provisional application 61/883,163, filed on Sep. 26, 2013.
Prior Publication US 2023/0241318 A1, Aug. 3, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/20 (2006.01); A61M 5/315 (2006.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01)
CPC A61M 5/20 (2013.01) [A61M 5/31568 (2013.01); A61M 5/31571 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 40/63 (2018.01); A61M 5/31525 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/50 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2205/8206 (2013.01); G16H 20/17 (2018.01); G16H 40/67 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A system, comprising:
an injection pen device configured to administer medicine to a patient; and
a software application installable on a mobile communication device in communication with the injection pen device, the mobile communication device having one or more processors and one or more processor-readable media storing the software application which, when executed by the one or more processors, causes performance of:
determining a blood glucose level of the patient;
determining a rate of change of the blood glucose level;
determining a blood glucose trend based on the rate of change of the blood glucose level;
calculating a recommended dose of medicine for administering to the patient via the injection pen device based on the blood glucose level and the blood glucose trend; and
displaying the recommended dose of medicine via at least one of a display of the injection pen device or a display of the mobile communication device.